Collegium Pharmaceutical
Neurology & CNS Therapeutics · Prescription Drugs
1open role
$150kmedian advertised pay
Growinghiring pace, 71 of 100
7cities with offices
Jobs
$185k – $230k per year · In office · 5+ years exp · Master's Degree · Los Angeles
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$150k
Typical range
$150k – $280k
Open positions
7
7
Jobs
Junior
57.1%
Senior
28.6%
Architect
14.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 4 | $150k | $150k |
| Senior | 2 | $205k | $180k – $230k |
| Architect | 1 | $280k | $280k |
Highest paying role
Area Sales Director - West
$280k
Normalized to USD per year
All salaries at Collegium Pharmaceutical
By role, level and city, against the market · 7 jobs with pay
Visa sponsorship
2
H-1B filings in 12 months
$178k
Median offered salary
7
Open roles in United States
Who they sponsor
Other managers
1
Data scientists
1
In the register as Collegium Pharmaceutical, Inc., Stoughton, MA
Other sponsors in the same field
AbbVie 
Biogen 
Novartis
See 7 open roles Alert me
US Department of Labor · latest filing Mar 24, 2026 · Visa details by country
Growth
Hiring Momentum
71/100
Growing
Open positions
8
1 opened / 3 closed in 30 days
Median time-to-fill
24 days
faster than 53% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
53% ▲
Analytics
16% ▼
HR
11% ▲
Leadership
5% ▼
Finance
5% ▲
Legal
5% ▼
Activity Timeline
New location: Atlanta
Nov 2026
New location: Los Angeles
Oct 2026
New location: Phoenix
Oct 2026
+3 jobs in a week
Oct 2026
New location: Dublin
Oct 2026
New location: Salt Lake City
Oct 2026
New location: Framingham
Oct 2026
New location: Raleigh
Sep 2026
New location: Montgomery
Sep 2026
New location: Worcester
Sep 2026
Added Machine Learning to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
People
Shirley Kuhlmann
Executive Officer
Alison Fleming
Executive Officer
Scott Dreyer
Executive Officer
Joseph Ciaffoni
Executive Officer, Director
Paul Brannelly
Executive Officer
Michael Heffernan
Director
David Hirsch
Director
Garen Bohlin
Director
Theodore Schroeder
Director
John Fallon
Director
Gwen Melincoff
Director
Gino Santini
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Collegium Pharmaceutical over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
6
Stack modernity
71/100
Languages
SQL
Databases
Amazon Redshift
Cloud & platforms
Power BI
Developer tools
Microsoft Excel
Practices & domains
Machine Learning
NLP
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
EcoR1 CapitalVia a fund
Longitude CapitalVia a fund
78 portfolio companies: Zenas BioPharma, Mobia Medical, Inc. and 76 more
RA Capital ManagementVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Collegium Pharmaceutical, Inc. (COLL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Read more
Report
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback
Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.
Read more
Report
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025
An executive vice president at a top pharmaceutical company sold shares towards the end of 2025, while the company's shares reached record numbers that year.
Read more
Report
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2%
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) reported Q2 CY2025 results beating Wall Street's revenue expectations, with sales up 29.4% year on year to $188 million. The company's full-year revenue guidance of $752.5 million at the midpoi
Read more
Report
Why Collegium Pharmaceutical (COLL) Stock Might be a Great Pick
One stock that might be an intriguing choice for investors right now is Collegium Pharmaceutical, Inc. COLL. This is because this security in the Medical - Drugs space is seeing solid earnings estimate revision activity, and is in
Read more
Report
Offices
Where the company hires and what each office is for
Cities
7
Hiring now
6
Countries
1
Busiest office
Boston
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Stoughton
United States
HQ
100 Technology Center Drive, Suite 300
Boston
United States
Stoughton, MA
2 open roles 7 posted in 90 days $180k Avg Salary
hires for Finance, Legal
Montgomery
United States
Sales office
Remote
1 open roles 1 posted in 90 days $150k Avg Salary
hires for Sales
Salt Lake City
United States
Sales office
Remote
1 open roles 1 posted in 90 days $150k Avg Salary
hires for Sales
Phoenix
United States
Sales office
Remote
1 open roles 1 posted in 90 days $280k Avg Salary
hires for Sales
Los Angeles
United States
Remote
1 open roles 1 posted in 90 days $230k Avg Salary
hires for Biotech
Atlanta
United States
Sales office
Remote
1 open roles 1 posted in 90 days $150k Avg Salary
hires for Sales
Earlier presence
Chicago, United States
Denver, United States
Greensboro, United States
Raleigh, United States
Framingham, United States